
Next Gen
Neurostimulation
Stim2Go can be used to mitigate lower limb spasticity after spinal cord injury and in patients with multiple sclerosis through the application of non-invasive transcutaneous spinal cord stimulation (tSCS). The stimulation is typically performed in a supine or standing posture, and its effects may last for several hours. The application of tSCS can also be incorporated into secured gait therapy to further enhance gait rehabilitation in cases of incomplete spinal cord injury.
The spasticity reduction programs are available only within the scope of MDR approval and are not cleared for market by the FDA.

| Spasticity reduction 50 Hz 1CH | |
| Spasticity reduction 33 Hz 1CH |
Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Please contact your country representative for product availability and information. Product images are for reference only.
The PAJUNK® website is available in different country/language versions.
Please select your preference:
Please note: Available products and applicable regulations may vary by country. If your country does not have a dedicated PAJUNK site please choose our Global site in English and contact our local Customer Service for country-specific information.


